S. 1289Senate109th Congress (2005-2007)In Committee

Uterine Fibroid Research and Education Act of 2005

A bill to provide for research and education with respect to uterine fibroids, and for other purposes.

Introduced June 22, 2005

Legislative Activity

Stay on top of the latest movement without scrolling through every action

2 earlier actions
SenateIntro Referral Latest Action

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

June 22, 2005

View full timeline
SenateIntro Referral

Introduced in Senate

June 22, 2005

SenateIntro Referral

Sponsor introductory remarks on measure. (CR S7075-7076)

June 22, 2005

SenateIntro Referral

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

June 22, 2005

Floor Debate

6 members

What members said about S. 1289 on the floor

1 Republican5 Democrats
Barbara A. Mikulski
Sen. Barbara A. MikulskiD-MD · Jun 22, 2005

Mr. President, I rise to introduce the Uterine Fibroid Research and Education Act of 2005. This bill would increase funding for research on uterine fibroids as well as create an education awareness…

Barbara A. Mikulski
Sen. Barbara A. MikulskiD-MD · Jun 22, 2005

Mr. President, I rise to introduce the Uterine Fibroid Research and Education Act of 2005. This bill would increase funding for research on uterine fibroids as well as create an education awareness…

Norm Coleman
Sen. Norm ColemanR-MN · Jun 22, 2005

Mr. President, as United States Senators, we are well aware of the difficulty in making tough decisions. But, a tough decision for a thirteen-year-old foster care child shouldn't be choosing between…

Edward M. Kennedy
Sen. Edward M. KennedyD-MA · Jun 22, 2005

Mr. President, it's an honor to join Senator Corzine and Congressman Weiner to introduce the Health Care Accountability Act. Americans believe that a fair day's work should bring a fair day's pay.…

Carl Levin
Sen. Carl LevinD-MI · Jun 22, 2005

Mr. President, I am proud to join with Senator Stabenow in introducing legislation to name the Federal building located at 333 Mt. Elliott Street in Detroit, MI, in honor of Mrs. Rosa Parks, ``mother…

Show 2 more
Debbie Stabenow
Sen. Debbie StabenowD-MI · Jun 22, 2005

Mr. President, I rise today to introduce legislation that will designate the Federal building located at 333 Mt. Elliott Street in Detroit, MI, as the ``Rosa Parks Federal Building.'' I want to thank…

Ron Wyden
Sen. Ron WydenD-OR · Jun 22, 2005

Mr. President, today I introduce legislation to authorize the Secretary of the Interior to enter into cooperative agreements to protect National Parks through collaborative efforts on lands inside…

Bill Text

Latest available legislative text

Reading Mode
Latest
Introduced in SenateIssued June 22, 2005

II

109th CONGRESS

1st Session

S. 1289

IN THE SENATE OF THE UNITED STATES

June 22, 2005

Ms. Mikulski (for herself, Mrs. Clinton, Mr. Kennedy, Mrs. Murray, Mrs. Boxer, Ms. Cantwell, and Mr. Sarbanes) introduced the following bill; which was read twice and referred to the Committee on Health, Education, Labor, and Pensions

A BILL

To provide for research and education with respect to uterine fibroids, and for other purposes.

1.

Short title

This Act may be cited as the Uterine Fibroid Research and Education Act of 2005.

2.

Findings

Congress finds as follows:

(1)

The development of uterine fibroids is a common and significant health problem, affecting women, primarily of reproductive age, across all ages, racial backgrounds, and socioeconomic levels.

(2)

It is estimated that between 20 and 30 percent of women of reproductive age have clinically recognized uterine fibroids, and screening studies indicate the prevalence of uterine fibroids in women may be much higher.

(3)

Minority women are more likely to develop uterine fibroids, and through ultrasound screening of African American and Caucasian women for fibroids, it is estimated that more than 80 percent of African Americans and about 70 percent of Caucasians develop fibroids by the time they reach menopause and the tumors develop at younger ages in African Americans.

(4)

Symptomatic uterine fibroids can cause heavy bleeding, pain, and reproductive problems, including infertility. There is no known cause of uterine fibroids.

(5)

The presence of uterine fibroids is the most common reason for hysterectomies, accounting for approximately one-third of hysterectomies, or 200,000 procedures annually and 22 percent of African American women and 7 percent of Caucasians have hysterectomies for fibroids.

(6)

Over five billion dollars are spent annually on hysterectomies, at approximately $6,000 for each surgery.

(7)

The Evidence Report and Summary on the Management of Uterine Fibroids, as compiled by the Agency for Healthcare Research and Quality of the Department of Health and Human Services, held that there is a remarkable lack of high quality evidence supporting the effectiveness of most interventions for symptomatic fibroids.

(8)

Current research and available data do not provide adequate information on the rates of prevalence and incidents of fibroids in Asian, Hispanic, and other minority women, the costs associated with treating fibroids, and the methods by which fibroids may be prevented in these women.

3.

Research with respect to uterine fibroids

(a)

Research

The Director of the National Institutes of Health (in this section referred to as the Director of NIH) shall expand, intensify, and coordinate programs for the conduct and support of research with respect to uterine fibroids.

(b)

Administration

The Director of NIH shall carry out this section through the appropriate institutes, offices, and centers of the National Institutes of Health, including the National Institute of Child Health and Human Development, the National Institute of Environmental Health Sciences, the Office of Research on Women’s Health, and the National Center on Minority Health and Health Disparities.

(c)

Coordination of activities

The Office of Research on Women’s Health shall coordinate activities under subsection (b) among the institutes, offices, and centers of the National Institutes of Health.

(d)

Authorization of appropriations

For the purpose of carrying out this section, there are authorized to be appropriated $30,000,000 for each of the fiscal years 2006 through 2010.

4.

Education and dissemination of information with respect to uterine fibroids

(a)

Uterine fibroids public education program

The Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention, shall develop and disseminate to the public information regarding uterine fibroids, including information on—

(1)

the incidence and prevalence of uterine fibroids among women;

(2)

the elevated risk for minority women to develop uterine fibroids; and

(3)

the availability, as medically appropriate, of a range of treatment options for symptomatic uterine fibroids.

(b)

Dissemination of information

The Secretary may disseminate information under subsection (a) directly or through arrangements with nonprofit organizations, consumer groups, institutions of higher education, Federal, State, or local agencies, or the media.

(c)

Authorization of appropriations

For the purpose of carrying out this section, there are authorized to be appropriated such sums as may be necessary for each of the fiscal years 2006 through 2010.

5.

Information to health care providers with respect to uterine fibroids

(a)

Dissemination of information

The Secretary of Health and Human Services, acting through the Administrator of the Health Resources and Services Administration, shall develop and disseminate to health care providers information on uterine fibroids for the purpose of ensuring that health care providers remain informed about current information on uterine fibroids. Such information shall include the elevated risk for minority women to develop uterine fibroids and the range of available options for the treatment of symptomatic uterine fibroids.

(b)

Authorization of appropriations

For the purpose of carrying out this section, there are authorized to be appropriated such sums as may be necessary for each of the fiscal years 2006 through 2010.

6.

Definition

In this Act, the term minority women means women who are members of a racial and ethnic minority group, as defined in section 1707(g) of the Public Health Service Act (42 U.S.C. 300u–6(g)).